The role of p53 in breast cancer has been the subject of much debate (Staples et al, 2008) with recent clarity that p53 mutation is a marker of biologically aggressive disease (Olivier et al, 2006; Staples et al, 2008) and response to therapy (Staples et al, 2008). This evidence concerns the gene TP53 and breast carcinoma.